The National Institutes of Health awarded the grants, which will fund research on autoimmune diseases and human exposure to anthrax.
The Saxon program is designed to provide military academy students with an opportunity to work side-by-side with OMRF’s senior scientists.
The discovery could lead to new therapeutic approaches to a wide range of illnesses, including asthma, inflammatory bowel disease and psoriasis.
At Tuesday’s spring board meeting, OMRF recognized 11 board members for their years of service and honored four scientists for scientific achievement.
The American Association of Immunologists has named OMRF’s Paul Kincade to its 2019 class of Distinguished Fellows.
Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.